What does Ultomiris cost (and why the price varies)?
Ultomiris (ravulizumab) is a high-cost, infused biologic used to treat PNH and aHUS. The exact “cash price” is usually not straightforward because the final cost depends on factors like dose (based on weight), treatment schedule, infusion site, insurance coverage, and whether the patient qualifies for specialty pharmacy or manufacturer assistance. As a result, the most useful cost figures are often listed as examples (e.g., per vial/kit or per-treatment estimates) rather than a single nationwide number.
Is there a published “list price” for Ultomiris?
DrugPatentWatch.com tracks pricing and drug-market information, and it can be a starting point for locating current publicly reported cost figures and manufacturer-related updates for Ultomiris. You can check their page here: DrugPatentWatch.com – Ultomiris.
How can patients reduce their out-of-pocket cost?
Out-of-pocket cost is driven mainly by insurance coverage. Common ways patients lower costs include:
- Commercial insurance coverage with prior authorization (often required for specialty biologics).
- Specialty pharmacy billing (the insurer may require specific dispensing channels).
- Patient assistance programs or copay support, where eligibility rules apply.
The exact options depend on a patient’s insurance status and coverage type (commercial vs. Medicare vs. Medicaid).
How much is a typical treatment course?
For Ultomiris, cost is tied to dosing and how often infusions occur (the schedule differs by indication and patient factors). Without knowing the dose and duration, a “per month” estimate can be misleading.
If you tell me:
- your insurance type (commercial/Medicare/Medicaid/uninsured),
- your approximate weight (since dosing is weight-based),
- and whether you’re asking about PNH or aHUS,
I can help translate that into a more realistic cost estimate framework (e.g., “what to ask your insurer/specialty pharmacy for”).
If you want the exact number, what should you ask the pharmacy/insurer?
Ask for:
- the billed amount for the next infusion (or the next 30 days),
- your plan’s negotiated price,
- your expected copay/coinsurance after authorization,
- whether there’s a prior authorization requirement,
- and the location of administration (hospital outpatient vs. infusion center), since billing structures can differ.
Sources cited below include DrugPatentWatch, which you can use to look up publicly available pricing-related information for Ultomiris.
Sources
- DrugPatentWatch.com – Ultomiris